337 related articles for article (PubMed ID: 23873832)
1. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA TALNEC2 plays an oncogenic role in breast cancer by binding to EZH2 to target p57
Qiao E; Chen D; Li Q; Feng W; Yu X; Zhang X; Xia L; Jin J; Yang H
J Cell Biochem; 2019 Mar; 120(3):3978-3988. PubMed ID: 30378143
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors.
Lu Z; Hunter T
Cell Cycle; 2010 Jun; 9(12):2342-52. PubMed ID: 20519948
[TBL] [Abstract][Full Text] [Related]
4. p57KIP2: "Kip"ing the cell under control.
Pateras IS; Apostolopoulou K; Niforou K; Kotsinas A; Gorgoulis VG
Mol Cancer Res; 2009 Dec; 7(12):1902-19. PubMed ID: 19934273
[TBL] [Abstract][Full Text] [Related]
5. The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer.
Zohny SF; Baothman OA; El-Shinawi M; Al-Malki AL; Zamzami MA; Choudhry H
Cancer Biomark; 2017; 18(4):413-423. PubMed ID: 28106536
[TBL] [Abstract][Full Text] [Related]
6. Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer.
Puhalla H; Wrba F; Kandioler D; Lehnert M; Huynh A; Gruenberger T; Tamandl D; Filipits M
Anticancer Res; 2007; 27(3B):1679-84. PubMed ID: 17595796
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of p57kip² promotes cell invasion via LIMK/cofilin pathway in human nasopharyngeal carcinoma cells.
Chow SE; Wang JS; Lin MR; Lee CL
J Cell Biochem; 2011 Nov; 112(11):3459-68. PubMed ID: 21769918
[TBL] [Abstract][Full Text] [Related]
8. CDK inhibitor p57 (Kip2) is downregulated by Akt during HER2-mediated tumorigenicity.
Zhao R; Yang HY; Shin J; Phan L; Fang L; Che TF; Su CH; Yeung SC; Lee MH
Cell Cycle; 2013 Mar; 12(6):935-43. PubMed ID: 23421998
[TBL] [Abstract][Full Text] [Related]
9. BMP2 and BMP6 control p57(Kip2) expression and cell growth arrest/terminal differentiation in normal primary human epidermal keratinocytes.
Gosselet FP; Magnaldo T; Culerrier RM; Sarasin A; Ehrhart JC
Cell Signal; 2007 Apr; 19(4):731-9. PubMed ID: 17112701
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Sp1 transcription factor.
Cucciolla V; Borriello A; Criscuolo M; Sinisi AA; Bencivenga D; Tramontano A; Scudieri AC; Oliva A; Zappia V; Della Ragione F
Carcinogenesis; 2008 Mar; 29(3):560-7. PubMed ID: 18204075
[TBL] [Abstract][Full Text] [Related]
11. A new ubiquitin ligase involved in p57KIP2 proteolysis regulates osteoblast cell differentiation.
Kim M; Nakamoto T; Nishimori S; Tanaka K; Chiba T
EMBO Rep; 2008 Sep; 9(9):878-84. PubMed ID: 18660753
[TBL] [Abstract][Full Text] [Related]
12. [Expression of PAK4 in breast cancer and benign breast pathological changes].
Yang JX; Han YJ; Zheng H; Luo RC
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):981-3. PubMed ID: 20501374
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of the KIP family members p27(KIP1) and p57(KIP2) by SKP2 and the role of methylation in p57(KIP2) inactivation in nonsmall cell lung cancer.
Pateras IS; Apostolopoulou K; Koutsami M; Evangelou K; Tsantoulis P; Liloglou T; Nikolaidis G; Sigala F; Kittas C; Field JK; Kotsinas A; Gorgoulis VG
Int J Cancer; 2006 Dec; 119(11):2546-56. PubMed ID: 16988944
[TBL] [Abstract][Full Text] [Related]
14. The Cdk inhibitor p57(Kip2) controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics.
Vlachos P; Joseph B
Oncogene; 2009 Nov; 28(47):4175-88. PubMed ID: 19734939
[TBL] [Abstract][Full Text] [Related]
15. The cyclin kinase inhibitor p57kip2 regulates TGF-beta-induced compensatory tubular hypertrophy: effect of the immunomodulator AS101.
Sinuani I; Weissgarten J; Beberashvili I; Rapoport MJ; Sandbank J; Feldman L; Albeck M; Averbukh Z; Sredni B
Nephrol Dial Transplant; 2009 Aug; 24(8):2328-38. PubMed ID: 19321762
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of p57Kip2 induces prostate cancer in the mouse.
Jin RJ; Lho Y; Wang Y; Ao M; Revelo MP; Hayward SW; Wills ML; Logan SK; Zhang P; Matusik RJ
Cancer Res; 2008 May; 68(10):3601-8. PubMed ID: 18483241
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide expression profiling of placentas in the p57Kip2 model of pre-eclampsia.
Knox KS; Baker JC
Mol Hum Reprod; 2007 Apr; 13(4):251-63. PubMed ID: 17289831
[TBL] [Abstract][Full Text] [Related]
18. Expressions of cyclin E, cyclin dependent kinase 2 and p57(KIP2) in human gastric cancer.
Liang B; Wang S; Yang X; Ye Y; Yu Y; Cui Z
Chin Med J (Engl); 2003 Jan; 116(1):20-3. PubMed ID: 12667381
[TBL] [Abstract][Full Text] [Related]
19. Cyclic changes in the expression of p57(kip2) in human endometrium and its regulation by steroid hormones in endometrial stromal cells in vitro.
Kim ST; Lee SK; Gye MC
Reprod Sci; 2012 Jan; 19(1):92-101. PubMed ID: 22064387
[TBL] [Abstract][Full Text] [Related]
20. Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma.
Zhang HJ; Siu MK; Yeung MC; Jiang LL; Mak VC; Ngan HY; Wong OG; Zhang HQ; Cheung AN
Carcinogenesis; 2011 May; 32(5):765-71. PubMed ID: 21325635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
